The entity denotes a SINAN surveillance concept for anti-rabies care administered after exposure, as defined by the Brazil Ministry of Health notification system [3]. It reflects post-exposure prophylactic measures against rabies virus infection rather than a clinical disease category [4].
Disease overview
OtherRabies post-exposure prophylaxis is a public-health intervention applied after potential exposure to rabies virus, encompassing wound care, vaccination, and immunoglobulin in severe exposures [1]. Approximately 15 million people receive such prophylaxis each year worldwide [2]. Surveillance systems such as Brazil's SINAN record this care as a notifiable health event following exposure [3].
Read the full clinical and epidemiological profile 2
- 1 Kessels J et al. Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course. Vaccine. 2019 Oct 3. PMID: 30737043. doi: 10.1016/j.vaccine.2019.01.041. PubMed: https://pubmed.ncbi.nlm.nih.gov/30737043/
- 2 Singh R et al. Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q. 2017 Dec. PMID: 28643547. doi: 10.1080/01652176.2017.1343516. PubMed: https://pubmed.ncbi.nlm.nih.gov/28643547/
- 3 Brazil Ministry of Health SINAN. SINAN registry entity: Rabies post-exposure prophylaxis [Internet]. cited 23 Oct 2026. Available from: https://www.gov.br/saude/pt-br/composicao/svsa/sistemas-de-informacao/sinan
- 4 Ilina EN et al. Recombinant Monoclonal Antibodies for Rabies Post-exposure Prophylaxis. Biochemistry (Mosc). 2018 Jan. PMID: 29534663. doi: 10.1134/S0006297918010017. PubMed: https://pubmed.ncbi.nlm.nih.gov/29534663/
- Z20.3
Loading current data…
Country surveillance trends
Choose a country, source, and measure. Each line retains its published reporting period and definition.
Coverage
Reporting countries and regions
The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.
Loading current data…
Surveillance pattern
Year × month seasonality by country
Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.
Research Radar
Recent related research
Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial
International Journal of Infectious Diseases
Progress towards dog-mediated rabies elimination in PR China: a scoping review
Infectious Diseases of Poverty
Fatal Human Rabies Infection With Suspected Host-Mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure—Minnesota, 2021
Clinical Infectious Diseases
On the path to rabies elimination: The need for risk assessments to improve administration of post-exposure prophylaxis
Vaccine
Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014–2016
Vaccine
Showing 5 of 6 related publications.
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Loading official alerts…
Downloads and methods
Choose a time range and download CSV, JSON or XLSX files.

